Literature DB >> 10573490

Dobutamine echocardiography predicts functional outcome after revascularisation in patients with dysfunctional myocardium irrespective of the perfusion pattern on resting thallium-201 imaging.

R Senior1, A Lahiri.   

Abstract

OBJECTIVE: To evaluate whether the predictive value of dobutamine echocardiography for assessing contractile reserve was altered by differing patterns of regional myocardial perfusion. PATIENTS: 31 consecutive patients with symptomatic congestive heart failure (left ventricular ejection fraction < 35%) caused by coronary artery disease.
SETTING: A district general hospital.
METHODS: Thallium-201 perfusion imaging and low dose dobutamine (5-15 microg/kg/min) echocardiography were performed and resting echocardiography was repeated three months after revascularisation. Perfusion pattern and systolic wall thickening were compared using a 12 segment left ventricular model.
RESULTS: Of the 273 severely dysfunctional segments, 106 (39%) showed a normal perfusion and 167 (61%) an abnormal pattern. After revascularisation, recovery occurred in 71 of the segments with a normal perfusion pattern, and in these a dobutamine response was observed in 61 (86%); recovery also occurred in 56 segments with a mild to moderate abnormality of perfusion, and in these a dobutamine response was seen in 46 (81%) (NS). After revascularisation, the positive and negative predictive values for recovery of dysfunctional segments, where the majority were abnormally perfused, were 88% and 86%, respectively. Systolic wall thickening score indices improved from (mean (SD)) 3.21 (0.58) to 2. 6 (0.66) (p < 0.001) after revascularisation in dobutamine responsive patients (n = 24) compared with patients who did not show a dobutamine response (2.86 (0.65) and 3.13 (0.56), p = 0.61, respectively).
CONCLUSIONS: Dobutamine echocardiography predicted improvement of dysfunctional myocardium after revascularisation irrespective of the resting perfusion pattern seen.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573490      PMCID: PMC1729220          DOI: 10.1136/hrt.82.6.668

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  29 in total

1.  Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion.

Authors:  H W Strauss; K Harrison; J K Langan; E Lebowitz; B Pitt
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

2.  Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts.

Authors:  H Baumgartner; G Porenta; Y K Lau; M Wutte; U Klaar; M Mehrabi; R J Siegel; J Czernin; G Laufer; H Sochor; H Schelbert; M C Fishbein; G Maurer
Journal:  J Am Coll Cardiol       Date:  1998-11-15       Impact factor: 24.094

3.  Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease.

Authors:  S L Meyer; G C Curry; M S Donsky; D B Twieg; R W Parkey; J T Willerson
Journal:  Am J Cardiol       Date:  1976-07       Impact factor: 2.778

4.  Assessment of myocardial perfusion and contractile function by inotropic stress Tc-99m sestamibi SPECT imaging and echocardiography for optimal detection of multivessel coronary artery disease.

Authors:  R S Khattar; R Senior; A Lahiri
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

5.  Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.

Authors:  B L Gerber; J L Vanoverschelde; A Bol; C Michel; D Labar; W Wijns; J A Melin
Journal:  Circulation       Date:  1996-08-15       Impact factor: 29.690

6.  Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium.

Authors:  K T Sun; J Czernin; J Krivokapich; Y K Lau; M Böttcher; G Maurer; M E Phelps; H R Schelbert
Journal:  Circulation       Date:  1996-12-15       Impact factor: 29.690

7.  Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs.

Authors:  J T Willerson; I Hutton; J T Watson; M R Platt; G H Templeton
Journal:  Circulation       Date:  1976-05       Impact factor: 29.690

8.  Evaluation of patterns of perfusion and metabolism in dobutamine-responsive myocardium.

Authors:  S Sawada; G Elsner; D S Segar; M O'Shaughnessy; S Khouri; J Foltz; P D Bourdillon; J R Bates; N Fineberg; T Ryan; G D Hutchins; H Feigenbaum
Journal:  J Am Coll Cardiol       Date:  1997-01       Impact factor: 24.094

9.  Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction.

Authors:  J L Vanoverschelde; A M D'Hondt; T Marwick; B L Gerber; M De Kock; R Dion; W Wijns; J A Melin
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

10.  Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularisation in severe ischaemic left ventricular dysfunction.

Authors:  R Senior; B Glenville; S Basu; B S Sridhara; E Anagnostou; R Stanbridge; S J Edmondson; C E Handler; E B Raftery; A Lahiri
Journal:  Br Heart J       Date:  1995-10
View more
  6 in total

Review 1.  Stress echocardiography for the diagnosis and risk stratification of patients with suspected or known coronary artery disease: a critical appraisal. Supported by the British Society of Echocardiography.

Authors:  R Senior; M Monaghan; H Becher; J Mayet; P Nihoyannopoulos
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

2.  Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking beta blockers: accuracy and optimal dose.

Authors:  T Zaglavara; R Haaverstad; B Cumberledge; T Irvine; H Karvounis; G Parharidis; G Louridas; A Kenny
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

Review 3.  Diagnostic and imaging considerations: role of viability.

Authors:  Roxy Senior
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

4.  Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium.

Authors:  H Yamagishi; K Akioka; K Hirata; Y Sakanoue; I Toda; M Yoshiyama; M Teragaki; K Takeuchi; J Yoshikawa; H Ochi
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

5.  Prognostic validation of an algorithm to convert myocardial perfusion SPECT imaging data from a 12-segment model to a 17-segment model.

Authors:  Michael Salerno; Laine Elliot; Linda K Shaw; Jonathan P Piccini; Robert Pagnanelli; Salvador Borges-Neto
Journal:  J Nucl Cardiol       Date:  2009-06-03       Impact factor: 5.952

Review 6.  Efficacy of noninvasive cardiac imaging tests in diagnosis and management of stable coronary artery disease.

Authors:  Ify R Mordi; Athar A Badar; R John Irving; Jonathan R Weir-McCall; J Graeme Houston; Chim C Lang
Journal:  Vasc Health Risk Manag       Date:  2017-11-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.